News
-
BioVersys Opens IPO Season at SIX Swiss Exchange
Today, BioVersys, a leading Swiss biotech company specializing in novel antibacterial products for serious life-threatening infections, listed its shares at SIX Swiss Exchange. At an…
startupticker.ch
-
SAEKI raises $6.7M to transform large-scale manufacturing
As AI accelerates design capabilities, SAEKI is bridging the widening gap between what engineers can design and what can actually be manufactured, end to end.…
startupticker.ch
-
CHF 2.4 billion for Swiss start-ups
Investment in knowledge-based start-ups fell again in 2024, by 8.5% compared with the previous year. The number of financing rounds also fell for the first…
startupticker.ch
-
Frank Thelen invests in Akina’s CHF 2.8 million seed round
Through its investment in Akina, Freigeist Capital, the Deep Tech VC founded by Frank Thelen, has led its first investment in the healthtech sector. The…
startupticker.ch
-
Start-up boom thriving at ETH Zurich
Once again, around 40 spin-off companies were launched at ETH Zurich. Start-ups in the fields of artificial intelligence and biotechnology were particularly well represented.
startupticker.ch
-
$16 million to fight forever chemicals
Swiss startup Oxyle announced a $16m funding round to scale its breakthrough solution to destroy, not just relocate, PFAS from wastewater. This builds on its…
startupticker.ch
-
$22 million for weather intelligence company
Meteomatics, the weather intelligence and technology company that enables the world’s leading companies to accurately forecast the weather’s impact on business, has closed its $22M…
startupticker.ch
-
BioVersys to go public next week
BioVersys started the offer period of its newly issued shares. Based on the offer price, the implied market capitalization of BioVersys is about CHF 212.9…
startupticker.ch
-
Spanish travel-tech unicorn acquires Yokoy
Yokoy, the leading spend management platform, has been acquired by TravelPerk, a business travel platform based in Barcelona. In parallel, TravelPerk announced the closing of…
startupticker.ch
-
AB2 Bio signs USD 600 million agreement with Nippon Shinyaku
AB2 Bio Ltd., developing therapies for the treatment of severe systemic hyperinflammatory diseases and conditions driven by IL-18, has entered into an option and licensing…
startupticker.ch
-
ZuriQ secures $4.2M seed funding to break quantum computing's scaling barrier
Quantum computing startup ZuriQ has today announced the closing of its $4.2 million seed funding round to commercialize a radical new architecture that will enable scaling…
startupticker.ch
-
Transmutex receives $4 million grant to enable nuclear waste transmutation
Geneva-based startup Transmutex has received more than $4.2 million from the U.S. Department of Energy Advanced Research Projects Agency-Energy as part of the NEWTON Program.…
startupticker.ch